XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2023   32,023,004      
Beginning balance at Dec. 31, 2023 $ 1,233,397 $ 32 $ 736,191 $ 495,383 $ 1,791
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 11,699     11,699  
Unrealized loss on investment, net of tax (442)       (442)
Stock-based compensation 1,529   1,538 (9)  
Issuance of restricted and deferred stock units (in shares)   30,432      
Issuance of restricted and deferred stock units (1,215)   (1,215)    
Employee stock purchase plan (in shares)   21,755      
Employee stock purchase plan 1,101   1,101    
Common stock issuance, net of costs (in shares)   126,025      
Common stock issuance, net of costs 7,006   7,006    
Dividends paid (12,824)     (12,824)  
Ending balance (in shares) at Mar. 31, 2024   32,201,216      
Ending balance at Mar. 31, 2024 $ 1,240,251 $ 32 744,621 494,249 1,349
Beginning balance (in shares) at Dec. 31, 2024 33,629,169 33,629,169      
Beginning balance at Dec. 31, 2024 $ 1,366,974 $ 34 827,796 537,184 1,960
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 16,551     16,551  
Stock-based compensation 1,201   1,210 (9)  
Issuance of restricted and deferred stock units (in shares)   31,587      
Issuance of restricted and deferred stock units (908)   (908)    
Employee stock purchase plan (in shares)   26,129      
Employee stock purchase plan 1,116   1,116    
Common stock issuance, net of costs (in shares)   495,900      
Common stock issuance, net of costs 26,545   26,545    
Dividends paid $ (14,142)     (14,142)  
Ending balance (in shares) at Mar. 31, 2025 34,182,785 34,182,785      
Ending balance at Mar. 31, 2025 $ 1,397,337 $ 34 $ 855,759 $ 539,584 $ 1,960